EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy

Indrani Nayak iD, Rosalba Biondo iD, William C Stewart, Rebecca J Fulton, Nina Möker, Congcong Zhang, Salim I Khakoo iD, Jayajit Das iD

Immunology & Cell Biology · 2025

DOI: 10.1111/imcb.12848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology & Cell Biology, 2025. Verfasst von Indrani Nayak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Interleukin-21, Killer Cells, Natural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, CRUK Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are emerging agents for cancer therapy. Several different cytokines are used to generate NK cells for adoptive immunotherapy including interleukin (IL)‐2, IL‐12, IL‐15 and IL‐18 in solution, and membrane‐bound IL‐21. These cytokines drive NK cell activation through the integration of signal transducers and activators of transcription (STAT) and nuclear factor‐kappa B (NF‐κB) pathways, which overlap and synergize, making it challenging to predict optimal cytokine combinations for both proliferation and cytotoxicity. We integrated functional assays for NK cells cultured in a variety of cytokine combinations with mathematical modeling using feature selection and mechanistic regression models. Our regression model successfully predicts NK cell proliferation for different cytokine combinations and indicates synergy of activated STATs and NF‐κB transcription factors between priming and post‐priming phases. The use of IL‐21 in solution in the priming of NK cell culture resulted in an improved NK cell proliferation, without compromising cytotoxicity potential or interferon gamma secretion against hepatocellular carcinoma cell lines. Our work provides an integrative framework for interrogating NK cell proliferation and activation for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveInterleukin-21Killer Cells, NaturalHumansCarcinoma, HepatocellularCell Line, TumorCell ProliferationCytotoxicity, ImmunologicImmunotherapyInterferon-gammaInterleukinsLiver NeoplasmsLymphocyte ActivationNF-kappa B

Stichwörter der Autor:innen

NK cellsSTATcytokineslinear regressionpredictive modelproliferation

Substanzen

Interferon-gammaInterleukin-21InterleukinsNF-kappa B

Autor:innen und Institutionen

  • Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
  • School of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
  • GIG Statistical Consulting, LLC, Columbus, OH, USA.
  • Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, USA.
  • Department of Pediatrics, The Ohio State University, Columbus, OH, USA.

ORCID-Profile: Indrani Nayak, Rosalba Biondo, Salim I Khakoo, Jayajit Das

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • CRUK Cancer Research UK
  • National Institutes of Health

Zitieren

APA

Nayak, I., Biondo, R., Stewart, W. C., Fulton, R. J., Möker, N., Zhang, C., Khakoo, S. I., & Das, J. (2025). Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12848

Vancouver

Nayak I, Biondo R, Stewart WC, Fulton RJ, Möker N, Zhang C, et al. Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy. Immunology & Cell Biology. 2025. doi:10.1111/imcb.12848

BibTeX
@article{Nayak2025,
  author = {Nayak, Indrani and Biondo, Rosalba and Stewart, William C and Fulton, Rebecca J and Möker, Nina and Zhang, Congcong and Khakoo, Salim I and Das, Jayajit},
  title = {Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy},
  journal = {Immunology & Cell Biology},
  year = {2025},
  doi = {10.1111/imcb.12848}
}
Kostenlos starten →